Send feedback

SMCHD1 p.Pro586Ser

c.1756C>T · VCV3722030

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.074 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0536%, eas)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
facioscapulohumeral muscular dystrophy 2

Computational evidence

Protein change
AlphaMissense0.074likely benign
REVEL0.013strongly benign-leaning
SaProtLLR -6.18tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.92GERP -0.38, phastCons 1
Regional constrainto/e 0.67unconstrained · MANE · 51 kb · p 2.2e-19 · regional, not allelic
Overall
CADD14.83PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0536% East Asian · 24/44,796 alleles
Filtering AF 0.0369% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0314%
Overall 0.00205% 33/1,612,794 alleles · ultra-rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.0536% 1,867
Finnishnot grpmax-eligible 0.00781% 12,798
European (non-Finnish) 0.000339% 294,815

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SMCHD1
Protein
p.Pro586Ser
Coding
c.1756C>T
MANE Select
NM_015295
Type
single nucleotide variant
Location
chr18:2703800 (GRCh38)
Gene constraint
LOEUF 0.342 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 81.17 · 1 PDB
Residue 586
a UniProt-annotated variant site (in fshd2); the 'atpase activity domain' region
Full SMCHD1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

facioscapulohumeral muscular dystrophy 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Facioscapulohumeral dystrophy (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/smchd1-p-pro586ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown